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1684-1182/Copyright ª 2014, TaiwanBackground/Purpose: The emergence of extended-spectrum b-lactamase (ESBL) OXA-142 gene
(blaOXA-142) in Pseudomonas aeruginosa has been reported in Bulgaria and other European
countries, but rarely in Asia.
Methods: From January 2009 to December 2012, 90 P. aeruginosa isolates with reduced suscep-
tibility or resistance to ceftazidime (minimum inhibitory concentration  8 mg/L) were
screened for ESBL and other broad-spectrum b-lactamase genes by polymerase chain reaction
and sequencing. Clonal relationship of the isolates was determined by pulsed-field gel electro-
phoresis.
Results: Three isolates were positive for ESBL production, exhibited resistance to ceftazidime,
and carried the blaOXA-142 gene. The blaOXA-142 gene was integrated into class 1 integron. Using
Southern blot analysis, blaOXA-142-containing integron was found to be located on a plasmid institute of Bioengineering, Tatung University, No. 40, Sector 3, Zhongshan North Road, Taipei, Taiwan.
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j.jmii.2014.11.017all three isolates. Eleven strains of P. aeruginosa carrying blaOXA-17 gene were found. The oprD
mutation was found in all the 21 ESBL strains of P. aeruginosa.
Conclusions: This study confirmed the presence of blaOXA-142-positive P. aeruginosa isolates in
Taiwan.
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reserved.Introduction
Pseudomonas aeruginosa is one of the most common causes
of healthcare-associated infections.1,2 The mechanism of
resistance to b-lactam drugs of P. aeruginosa can be
attributed to the acquisition of the b-lactamase gene,
inactivation of oprD causing outer-membrane imperme-
ability, or expression of broadly specific multidrug efflux
pump systems.3e5 The main b-lactamase genes include
those encoding for carbapenemase, extended-spectrum b-
lactamase (ESBL), and AmpC b-lactamase; all of which may
integrate into mobile elements that can carry multiple
resistance determinants and enable P. aeruginosa to ac-
quire multiple drug resistance. Recently, multidrug-resis-
tant P. aeruginosa isolates carrying ESBL blaOXA-142 gene
have emerged in Bulgaria.6 The ESBL blaOXA-142 gene is an
Amber class D b-lactamase gene. The OXA-type b-lacta-
mases, which have large sequence variation between indi-
vidual enzymes, can be categorized into five groups. The b-
lactamases OXA-10 and OXA-17 belong to OXA Group I. The
enzyme OXA-142 is an extended-spectrum derivative of
OXA-10-related enzymes. According to previous studies,
including the research project from the Centers for Disease
Control in Taiwan, no blaOXA-142-positive P. aeruginosa iso-
lates have been previously reported.7,8 Epidemiological
surveys have shown that P. aeruginosa sequence type (ST)
235 is predominantly responsible for the dissemination of P.
aeruginosa isolates in Europe, AsiaePacific area, and South
America.9e14 Due to the multidrug-resistance nature of P.
aeruginosa, clinical treatment is often difficult, where P.
aeruginosa continues to be frequently involved in many
healthcare-associated infections.
The aim of this study was to detect ESBL gene, especially
blaOXA-142 and other carbapenemase-encoding genes among
ceftazidime-resistant P. aeruginosa isolates in a medical
center in Taiwan. The clonal relationship of the isolates,
plasmid localization of the blaOXA-142 gene, and clinical
features of patients harboring isolates carrying blaOXA-142
were also determined. For further investigation of carba-
penems resistance, we also described genetic events that
could lead to the inactivation of oprD, causing outer-
membrane impermeability of P. aeruginosa.
Methods
Bacterial isolates collection, antimicrobial
susceptibility testing and patients characteristics
The 892 P. aeruginosa isolates were collected from January
2009 to December 2012 in Mackay Memorial Hospital, aLiu C-P, et al., Detection of Pse
iwan, Journal of Microbiology,2200-bed position hospital, in Taiwan. The 10.09% (90/892)
P. aeruginosa isolates with reduced susceptibility to cef-
tazidime [minimum inhibitory concentration (MIC)  8 mg/
L] were collected in the initial collection. Identification was
performed using the VITEK 2 system (bioMe´rieux Vitek
Systems, Hazelwood, MO, USA). MICs were determined via
agar dilution.15 The MICs of tested antibiotics, which
included ceftazidime, ciprofloxacin, amikacin, gentamicin,
and carbapenems (imipenem, meropenem and doripenem)
were interpreted according to the Clinical and Laboratory
Standards Institute (CLSI) guidelines.16 The MICs of colistin
were interpreted according to the CLSI and European
Committee on Antimicrobial Susceptibility Testing break-
point.17 Finally, a retrospective review of the patient
medical charts was performed to analyze the clinical in-
formation in patients harboring P. aeruginosa positive for
blaOXA-142. This study was approved by the Mackay Memorial
Institutional Review Board with the protocol number
13MMHIS218.
Carba NP test
Production of carbapenemases was phenotypically tested
with the Carba NP test. The supernatant from the enzy-
matic bacterial suspension of the tested strain was mixed
with 100-mL aliquots of a 1-mL solution that was made from
3 mg imipenem monohydrate (USP, Rockville, MD, USA),
phenol red (Merck Millipore, Billerica, MA, USA) solution,
and 0.1 mmol/L ZnSO4 (Merck Millipore) at pH of 7.8. A
mixture of the phenol red solution and the testing enzy-
matic suspension was incubated at 37C for a maximum of
2 hours.18
Polymerase chain reaction and sequencing
The 90 P. aeruginosa isolates were screened for carbape-
nemase genes such as blaIMP, blaVIM, blaNDM, blaSPM, blaAIM,
blaDIM, blaGIM, blaSIM, blaKPC, blaBIC, and blaOXA-48. They
were also screened for ESBL genes that included blaVEB,
blaPER, blaGES, blaTEM, blaSHV, blaCTX, blaBEL and blaPSE from
Class A; and blaOXA-group I, blaOXA-group II, blaOXA-group III from
Class D (Table 1).19e22 The screening for Class 1 integron and
sequencing of its cassettes was performed (Table 1).20,21
The detection of oprD genes and subsequent sequencing
procedures were also performed (Table 1).22 The polymer-
ase chain reaction (PCR) preparation procedure was as fol-
lows: bacteria were boiled in sterile water for 10 minutes;
the supernatant was collected and used as DNA sources for
PCR; the 25-mL reaction mixture consisted of 1 S-T Gold
buffer, 1.5 mM MgCl2, 0.2 mM dNTP, and 20 pmol of eachudomonas aeruginosa isolates carrying the blaOXA-142 extended-
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Figure 1. Number of blaOXA-type Pseudomonas aeruginosa
isolates from 2009 to 2012.
Table 1 Major oligonucleotide primers used in polymerase chain reaction
Primer Sequence (50e30) Use Refs
ABD1 TAT CGC GTG TCT TTC GAG TA blaOXA detection & probe for Southern blotting 19
ABD4 TTA GCC ACC AAT GAT GCC C blaOXA detection & probe for Southern blotting 19
pse-1-1a GTG TGA CAA TCA AAA TTA TG blaPSE-1 detection 20
Int1-6A ATA AGC CTG TTC GGT TCG TA Integron determination 21
qacE-2B GAT TTT AAT GCG GAT GTT GCG Integron determination 21
379OXA-10F GTT GGC GAA GTA AGA ATG CAG Integron sequencing This study
399OXA-10R CTG CAT TCT TAC TTC GCC AAC Integron sequencing This study
3end OXA-1a GAC AAC GAA AGT AAG TTG CC Integron sequencing This study
59OXA CCA GCT AAT GCC GTA CTC G Integron sequencing This study
5end OXA-1a CCT AGG AAC AAG GCT TGT CC Integron sequencing This study
3end3568OXA-2a CGA AGC GCC GCG CCC AGT GG Integron sequencing This study
pse-1-1b AGC GCG ACT GTG ATG TAT AA blaPSE-1 detection
21.
OprD.F GGA ACC TCA ACT ATC GCC AAG oprD detection22.
OprD.R GTT GCC TGT CGG TCG ATT AC oprD detection22.
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reagent (USB, Cleveland, OH, USA), and both strands were
sequenced using the standard dideoxynucleotide method in
an ABI Prism 377 DNA sequencer (Applied Biosystems, Foster
City, CA, USA). Sequence similarity searches were per-
formed with the basic local alignment search tool (BLAST)
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Pulsed-field gel electrophoresis and multilocus
sequence typing
The 90 P. aeruginosa isolates with reduced susceptibility
(MICs of ceftazidime  8 mg/L) were typed by pulsed-field
gel electrophoresis (PFGE) following digestion of intact
genomic DNA with SpeI (Biolabs, Beverly, MA, USA). The
DNA fragments were separated on 1% (w/v) SeaKem GTG
agarose gels in 0.5% TriseborateeEDTA buffer, in a CHEF
Mapper apparatus (Bio-Rad, Hercules, CA, USA) with a po-
tential of 6 V/cm, pulsed from 5 seconds to 35 seconds, for
22 hours at 14C.23 The completed gels were stained with
ethidium bromide and photographed with UV light. The SpeI
restriction profiles were initially compared with each other
by visual inspection and isolates were considered to be
closely related if they showed differences of less than three
bands.24 Computer-assisted analysis was also performed
using BioNumerics (Applied Maths, Sint-Martens-Latem,
Belgium). Cluster analysis was performed by the un-
weighted pair group method with mathematical averaging,
and DNA relatedness was calculated using the band-based
Dice coefficient with a tolerance setting of 1.0% band
tolerance and 1.0% optimization setting for the whole
profile.25 Isolates were considered to belong to the same
cluster when similarity coefficient reaches 80%.26 Finally,
multilocus sequence typing (MLST) was performed for the
blaOXA-positive P. aeruginosa isolate in accordance with the
protocol available at http://pubmlst.org/paeruginosa/.
Plasmid localization of the blaOXA-142 gene
To assess the plasmid location of blaOXA-142, Southern blot
analysis was performed with plasmid DNA. Plasmid DNA wasPlease cite this article in press as: Liu C-P, et al., Detection of Pse
spectrum b-lactamase gene in Taiwan, Journal of Microbiology,
j.jmii.2014.11.017extracted by using a plasmid maxi kit (Qiagen, Valencia,
CA, USA) and underwent agarose gel electrophoresis. After
transferring the DNA onto a nylon membrane (PerkinElmer,
Boston, MA, USA), the DNA was UV crosslinked and hybrid-
ized with the PCR-generated probes specific for blaOXA-142.
Labeling of the probes and hybridization signal detection
were carried out with digoxigenin DIG DNA Labeling and
Detection kit (Roche Diagnostics, Basel, Switzerland).
Results
Molecular typing of P. aeruginosa isolates positive
for blaOXA and carbapenamase genes
Twenty-one (21/90, 23.33%) P. aeruginosa isolates were
positive for ESBL genes, including four for blaOXA-10, 11 for
blaOXA-17, three for blaOXA-142, and three for blaPSE-1. The
number of blaOXA-positive P. aeruginosa isolates from 2009
to 2012 is shown in Fig. 1. Seven (7/90, 7.78%) P. aeruginosa
isolates were positive for carbapenemase genes, including
six with blaVIM-2 and one with blaVIM-3.udomonas aeruginosa isolates carrying the blaOXA-142 extended-
Immunology and Infection (2014), http://dx.doi.org/10.1016/
Figure 3. The MICs of P. aeruginosa isolates carrying blaOXA
4 C.-P. Liu et al.
+ MODELUsing PCR methods, these ESBL-positive isolates were
negative for blaIMP, blaVIM, blaNDM, blaSPM, blaAIM, blaDIM,
blaGIM, blaSIM, blaKPC, blaBIC, and blaOXA-48 carbapenemases
genes. All three isolates with blaOXA-142 belonged to ST 235
by MLST and resulted in closely related patterns with PFGE.
Comparison of PFGE patterns among ESBL-positive isolates
is demonstrated in Fig. 2. These 90 P. aeruginosa isolates
were classified by 46 PFGE patterns. Four isolates of blaOXA-
10, three isolates of blaOXA-142, one of 11 isolates of blaOXA-
17, one of 11 isolates of blaOXA-17, and the other nine of 11
isolates P. aeruginosa were classified as PFGE type 19, PFGE
type 37, PFGE type 35, PFGE type 36, and PFGE type 37,
respectively. The blaOXA-142 gene was integrated into Class 1
integron. Southern blot analysis showed that blaOXA-142 was
located on the plasmid in all three isolates with the blaOXA-
142 b-lactamase gene.genes for colistin (CLI) and three carbapenems (DOR: dor-
ipenem; MEM: meropenem; IPM: imipenem).Susceptibility testing of P. aeruginosa isolates
carrying blaOXA-142
Among the P. aeruginosa isolates carrying blaOXA-142 PA04,
PA17 and PA55, the MICs of imipenem were 16 mg/mL,
32 mg/mL and 16 mg/L, respectively. The MICs of mer-
openem were 16 mg/L for all three isolates. The MICs of
doripenem were 4 mg/mL, 8 mg/mL and 8 mg/L, respec-
tively. When compared with the other carbapenems, dor-
ipenem showed the lowest MICs in these threeFigure 2. Pulse-field gel electrophoresis of Pseudomonas aeru
Please cite this article in press as: Liu C-P, et al., Detection of Pse
spectrum b-lactamase gene in Taiwan, Journal of Microbiology,
j.jmii.2014.11.017ceftazidime-resistant P. aeruginosa isolates. The MICs of
colistin in these three isolates were 2 mg/L (Fig. 3). By
using the Carba NP test, these three isolates all tested
negative for carbapenemase. The MICs of P. aeruginosa
isolates carrying blaOXA genes for colistin and three car-
bapenems were demonstrated in Fig. 3. The MICs of other
tested antibiotics, including ciprofloxacin, amikacin and
gentamicin, were higher than the cut-off points of
resistance.ginosa isolates positive for extended-spectrum b-lactamase.
udomonas aeruginosa isolates carrying the blaOXA-142 extended-
Immunology and Infection (2014), http://dx.doi.org/10.1016/
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aeruginosa isolates carrying blaOXA
Characteristics of patients infected with P. aeruginosa
isolates carrying blaOXA are shown in Table 2. Among the
patients infected with blaOXA-142 positive P. aeruginosa,
Patient 7 (PA04) had diabetes and was bed-ridden due to a
cerebrovascular accident; he also had aspiration pneu-
monia complicated with bacteremia. The patient was
treated with colistin after blood culture results were
available, but he died within 24 hours after treatment was
initiated. Patient 5 (PA17) had asymptomatic urinary tract
infection associated with the use of a urinary catheter. The
urinary catheter was subsequently removed and the patient
was discharged without complications. Patient 6 (PA55)
underwent drainage of a retroperitoneal abscess that was
followed by secondary wound infection with blaOXA-142-
positive P. aeruginosa.Detection of oprD mutation
None of the isolates carried carbapenemases genes,
therefore, we determined whether there was a mutation in
the oprD. An oprD mutation was found in all of the ESBL-
positive P. aeruginosa. In the blaOXA-10-positive P. aerugi-
nosa, the oprD mutation resulted from a frameshift muta-
tion. Frameshift mutations were found in the PA4 and PA17
isolates of blaOXA-142-positive P. aeruginosa. The presence
of a premature stop codon was also found in the Pa55
isolate of blaOXA-142-positive P. aeruginosa. In blaOXA-17-
positive P. aeruginosa, oprD mutation was shown to arise
from various types of frameshift mutations and prematureTable 2 Characteristics of Pseudomonas aeruginosa isolates a
genes
No. PA isolate MICs (mg/L) Gene
CAZ IPM MEM DOR CLI
1 PA15 64 32 32 32 0.5 blaOX
2 PA73 64 32 16 16 0.5 blaOX
3 PA02 64 32 16 8 2 blaOX
4 PA11 64 32 8 8 0.5 blaOX
5 PA17 128 32 16 8 2 blaOX
6 PA55 128 16 16 8 2 blaOX
7 PA04 64 16 16 4 2 blaOX
8 PA43 32 32 64 16 0.5 blaOX
9 PA34 16 16 32 8 0.5 blaOX
10 PA26 16 16 32 8 0.5 blaOX
11 PA40 16 32 32 8 0.5 blaOX
12 PA14 16 16 16 8 0.5 blaOX
13 PA25 32 16 16 8 2 blaOX
14 PA89 16 16 16 8 2 blaOX
15 PA52 16 16 16 8 2 blaOX
16 PA32 32 32 16 8 2 blaOX
17 PA27 16 32 16 4 1 blaOX
18 PA35 64 16 16 4 0.5 blaOX
a oprD mutations A and B resulted in frameshift mutation and prem
CAZ Z ceftazidime; CLI Z colistin; DOR Z doripenem; ICU Z
MIC Z minimum inhibitory concentration.
Please cite this article in press as: Liu C-P, et al., Detection of Pse
spectrum b-lactamase gene in Taiwan, Journal of Microbiology,
j.jmii.2014.11.017stop codons. The oprD mutation of OXA type ESBL-positive
P. aeruginosa is summarized in Table 2. In the blaPSE-1-
positive P. aeruginosa, oprD mutation resulted from both
frameshift mutation and premature stop codon. PAO1 was
used as a reference for wild-type P. aeruginosa.Discussion
This study confirmed the presence of blaOXA-142-positive P.
aeruginosa in Taiwan. The blaOXA-142-positive P. aeruginosa
isolates first emerged in Europe, and we have now also
detected the presence of blaOXA-142-positive P. aeruginosa
isolates in Taiwan. For the purpose of epidemiological
surveys, we determined the clonal relationships among the
different strains of P. aeruginosa. Several molecular typing
methods were also used in determining the relationship
between P. aeruginosa and healthcare-associated in-
fections. The most recognized discriminatory method for
molecular typing, PFGE, has been a clinically valuable
method in evaluating short-term epidemiological P. aeru-
ginosa infections. However, another method, MLST is more
appropriate for evaluating long-term evolutionary re-
lationships in P. aeruginosa populations. The P. aeruginosa
ST 235 has been responsible for infections throughout
Europe, Asia, and South America.27
In this study, the three blaOXA-142-positive P. aeruginosa
isolates were shown to have closely related PFGE patterns,
and MLST showed that they belonged to ST 235. The three
isolates tested negative for carbapenemase in the Carba NP
and PCR screenings. Doripenem exhibited lower MICs to
blaOXA-142-positive P. aeruginosa isolates when compared to
the other two tested carbapenems, however, it did notnd patients infected/colonized with isolates carrying blaOXA
oprD mutationa Age/sex ICU stay Outcome
A-10 A 84/M No Survived
A-10 A 78/M No Survived
A-10 A 52/F No Survived
A-10 A 76/M No Survived
A-142 A 87/M Yes Survived
A-142 B 88/F Yes Survived
A-142 A 67/F Yes Died
A-17 B 48/M Yes Died
A-17 A, B 101/M No Survived
A-17 B 70/M No Survived
A-17 B 94/M No Survived
A-17 A, B 54/M No Survived
A-17 A, B 83/M No Survived
A-17 B 76/F Yes Died
A-17 B 68/F Yes Survived
A-17 B 76/F No Survived
A-17 A, B 65/F No Survived
A-17 B 71/F Yes Died
ature stop codon, respectively.
intensive care unit; IPM Z imipenem; MEM Z meropenem;
udomonas aeruginosa isolates carrying the blaOXA-142 extended-
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EUCAST or CLSI criteria. In contrast, colistin showed activ-
ities against all three blaOXA-142-positive P. aeruginosa iso-
lates using either the EUCAST or CLSI criteria.16,17
Two of the three isolates in our study caused healthcare-
associated infections and one isolate was regarded as a
noninfectious colonizer. One patient died from blaOXA-142-
positive P. aeruginosa bacteremia soon after the blood
culture result become available, despite treatment with
colistin. Due to concerns of potential renal toxicity of
colistin, physicians seldom prescribe colistin when empiri-
cally treating possible Gram-negative bacterial infections.
This inadequate medication may lead to acute life-
threatening situations when the infections are caused by
blaOXA-142-positive P. aeruginosa isolates. All of the blaOXA-
142 harboring integrons were integrated into plasmids. The
oprD mutation was also found in all of the ESBL strains of P.
aeruginosa. Frameshift mutation was found in PA04 and
PA17 of blaOXA-142-positive P. aeruginosa isolates. Prema-
ture stop codons were found in PA55 blaOXA-142-positive P.
aeruginosa isolate. Previous studies have indicated that the
oprD mutation plays an important role in resistance to
carbapenems.5,28 Although colistin is sensitive to P. aeru-
ginosa isolates carrying blaOXA genes in vitro, it would be
clinically limited in patients with both active infections and
renal insufficiency. The multiple resistance mechanism of
P. aeruginosa isolates carrying blaOXA genes lessens the
therapeutic options.
In conclusion, we report the detection of the first blaOXA-
142-positive P. aeruginosa isolates from Taiwan. The ESBL
blaOXA-142 gene was integrated to Class 1 integron in all
three isolates. All three isolates had blaOXA-142-containing
integron in plasmids. The commonest strain causing P.
aeruginosa infection in 2009 was blaOXA-17-positive P. aer-
uginosa. The oprD mutation was found in all the ESBL
strains of P. aeruginosa. Intensive care unit patients who
encounter blaOXA-142-positive P. aeruginosa and blaOXA-17-
positive P. aeruginosa may develop acute life-threatening
infections resulting in mortality.Conflicts of interest
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